-
Denali Therapeutics (NASDAQ:DNLI) Earns Outperform Rating from Analysts at Robert W. Baird
Source: Buzz FX / 07 Jan 2025 08:26:15 America/New_York
Denali Therapeutics (NASDAQ:DNLI) Earns Outperform Rating from Analysts at Robert W. Baird Written by MarketBeat January 7, 2025 Share Link copied to clipboard. Stock analysts at Robert W. Baird initiated coverage on shares of Denali Therap
Read more...